BOLD

Audentes Therapeutics, Inc
BOLD

Overview Fund Activity
Delisted

BOLD was delisted on the 14th of January, 2020.

Back to rankings

126 hedge funds and large institutions have $913M invested in Audentes Therapeutics, Inc in 2018 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 59 increasing their positions, 28 reducing their positions, and 11 closing their positions.

Holders
126
Holders Change
+12
Holders Change %
+10.53%
% of All Funds
2.81%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
23
Increased
59
Reduced
28
Closed
11
Calls
$1.05M
Puts
$446K
Net Calls
+$600K
Net Calls Change
-$208K

Top Buyers

1
GPP
1
Great Point Partners
Connecticut
$35.3M
2
PHS
2
PFM Health Sciences
California
$64.4M
3
BB
3
BB Biotech
Switzerland
$16.4M
4
Millennium Management
4
Millennium Management
New York
$12.6M
5
Citadel Advisors
5
Citadel Advisors
Florida
$22.7M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$19M
2
Franklin Resources
2
Franklin Resources
California
$0
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$67.2M
4
Lord, Abbett & Co
4
Lord, Abbett & Co
New Jersey
$9.22M
5
AllianceBernstein
5
AllianceBernstein
Tennessee
$4.63M
Name Market Value Shares Shares
Change 		Shares
Change %
Wellington Management Group
1
Wellington Management Group
Massachusetts
$72.1M 3,381,070 +77,668 +2%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$67.2M 3,151,884 -744,507 -19%
PHS
3
PFM Health Sciences
California
$64.4M 3,021,259 +1,467,120 +94%
BlackRock
4
BlackRock
New York
$63.4M 2,974,591 +406,605 +16%
RG
5
Redmile Group
California
$49.1M 2,301,667 +58,311 +3%
O
6
OrbiMed
New York
$40.4M 1,893,500 -286,500 -13%
Vanguard Group
7
Vanguard Group
Pennsylvania
$36.4M 1,706,529 +363,598 +27%
GPP
8
Great Point Partners
Connecticut
$35.3M 1,657,873 +1,657,873 New
State Street
9
State Street
Massachusetts
$34.8M 1,631,971 +351,528 +27%
VVM
10
Versant Venture Management
California
$25.7M 1,204,615 – –
Citadel Advisors
11
Citadel Advisors
Florida
$22.7M 1,063,850 +522,154 +96%
Jennison Associates
12
Jennison Associates
New York
$21.8M 1,024,691 -3,977 -0.4%
SI
13
Sofinnova Investments
California
$19.9M 933,640 – –
BBA
14
Baker Bros. Advisors
New York
$19.4M 910,463 +517,241 +132%
T. Rowe Price Associates
15
T. Rowe Price Associates
Maryland
$19M 891,181 -1,423,423 -61%
Victory Capital Management
16
Victory Capital Management
Texas
$18.4M 862,561 +101,200 +13%
CC
17
Casdin Capital
New York
$18.3M 860,000 +235,000 +38%
BB
18
BB Biotech
Switzerland
$16.4M 769,404 +769,404 New
NC
19
Nexthera Capital
New York
$16.3M 764,193 +223,021 +41%
AG
20
Artal Group
Luxembourg
$12.8M 600,000 +350,000 +140%
Millennium Management
21
Millennium Management
New York
$12.6M 590,974 +590,974 New
Dimensional Fund Advisors
22
Dimensional Fund Advisors
Texas
$12M 564,047 +394,602 +233%
GEM
23
Global Endowment Management
North Carolina
$10.7M 502,339 +502,339 New
RSCM
24
Rock Springs Capital Management
Maryland
$10.7M 500,000 +74,975 +18%
DM
25
Deerfield Management
New York
$10.5M 493,901 – –
1
2 3 4 5